2.4.2. Exclusion criteria
arrhythmia, cognitive impairment, mania, aggressive behavior, psychotic syndrome
INFECTIOUS DISEASES, ARRHYTHMIA, HEART DISEASE, ADVERSE EVENTS, HEARING LOSS
The exclusion criteria are the following: patients with cognitive impairment; patients with mania; deaf patients or hearing loss; patients with impaired eyesight and weak eyesight; patients with serious infectious diseases; non-cooperative or aggressive behavior (e.g., transient psychotic syndrome); patients with arrhythmia or heart disease; patients who discontinued radiopharmaceutical therapy midway; and those who are considered unsuitable to participate in the clinical trial by the researchers for other reasons.Standards and procedures for discontinuing the radiopharmaceutical therapy: if a participant happens with serious adverse events (SAE) during the study, the ethics committee considers discontinuing the study and treatment from an ethical perspective; the study should be discontinued due to the serious impact on the clinical study for other reasons.